INDICACIONES DE LA BIOPSIA DE MÉDULA ÓSEA

Miguel A. Martínez González, Ana García Marcilla, Mª Dolores Gómez Salazar y Juan López Pascual

BIBLIOGRAFÍA

   

  1. Ghedini G. Studi sulla patologia del midollo oseo umano vivente. Clin Med Ital 1908;47:724-736.

  2. Peabody FW. . Pathology of the bone marrow in pernicious anemia. Am J Pathol 1927;3:179-202.

  3. Arinkin MJ, Intravitale Untersuchungs Methodik des Knochenmarks. Folia Hematol 1929;38.233-240.

  4. Custer RP. Studies on the structure and function of bone marrow: Bone marrow biopsy. Am J Med Sci 1933;185:617-624.

  5. Damashek W, Henstell HH, Valentine EH. The comparative value and the limitations of the trephine and puncture methods for biopsy of the sternal marrow. 1934;11:801-818.

  6. Forteza Bover G. Atlas de histopatología de enfermedades de la sangre. Editorial Saber, Valencia 1956

  7. Block M. Bone marrow examination. Aspiration or core biopsy, smear or section, Hematoxilin-Eosin or Romanosky stain-Which combination?. Arch Pathol Lab Med 1976;100:454-456.

  8. Krause JR. An appraisal of the value of bone marrow biopsy in the assesement of proliferative lesions of the bone marrow. Histopathology 1983;7:627-644.

  9. Westerman MP. Bone marrow needle biopsy: An evaluation and critique. Semin Hematol 1981;18: 293-300

10. Brynes RK, McKenna RW, Sundberg RD. Bone marrow aspiration and trephine biopsy. An approach to a thorough study. Am J Clin Pathol 1978; 70:753.

11. Duhamel G. Histopathology clinique de la moelle osseuse. Chap I. pgs 3-11. Masson and C^ie. Paris 1974.

12. Ellis LD, Tensen WN, Westerman MF. Needle biopsy of bone marrow: An experience of 1445 biopsies. Arch Intern Med 1964;114:213-221.

13. Han T, Stutzman L and Roque AL. Bone marrow biopsy in Hodgkin´s disease and other neoplastic diseases. JAMA 1971; 217:1239-1241.

14. Bennet JM, Catovsky D, Daniel MT et al. Proposals for the classification of acute leukemias. French-American-British (FAB) Cooperative Group. Br J Haematol 1976;33:451-458.

15. Bennet JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative Group. Ann Intern Med 1985;103: 620-625

16. Winfield DA, Polacarz SV. Bone marrow histology 3: value of the bone marrow core biopsy in acute leukemia, myelodysplastic syndrome and chronic myeloid leukemia. J Clin Pathol 1992;45:855-859.

17. Horny HP, Wehrmann M, Steink B, Kaiserling E. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage associated antibodies. Human Pathol 1994;25:810-814.

18. Schultz KR; Massing B, Spinelli jj, Gaynon PS, Wadsworth l: Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia.

19. Burkhardt R. Bone marrow histology. In The leukemic cell Ed by D Catovsky, pags 49-86. Churchill and Livingston, New York 1981.

20. Rozman C, Monserrat E, Rodriguez JM et al. Bone marrow histologic pattern- the best single pronostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984;64:642-648.

21. Monserrat E, Villamor N, Reverter JC et al. Bone marrow assessment in B-cell Chronic lymphocytic leukemia: aspirate or biopsy?. A comparative study in 258 patients. Br J Haematol 1996;93:111-116.

22. Barlt R, Frish B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87:342-355.

23. Carbone A, Manconi R, Sulfaro S et al. Practical importance of routine paraffin-embedded bone marrow biopsy in multiple myeloma. Tumori 1987;73:315-319.

24. Krzyzaniak RL, Buss DH, Cooper MR; Wells Hb. Marrow fibrosis and multiple myeloma. Am J Clin Pathol 1988;89:63-68.

25. Longo DL. Trastornos de las células plasmáticas. En Harrison. Principios de Medicina Interna. Editado por KJ Isselbacher y cols. Cap 280 pags 1860-1868. Ed. Interamericana-Mc Graw Hill. Madrid 1994.

26. Burkhardt R, Bone marrow biopsy in malignant Lymphoma. In Bone marrow pathology, edited by K Lennert and K Hübner. Gustav Fischer Verlag. Stuttgart 1994 pgs 313-339.

27. Brunning RD, McKenna RW. Tumors of the bone marrow. In Atlas of tumor pathology 3^th series. Fascicle 9. Armed Forces Institute of Pathology. Washington DC, 1993.

28. Mahoney DH, Schreuders LC, Gresik MV McKlain KL. Role of staging bone marrow examination in children with Hodgkin disease. Med Pediatr Oncol 1998;30:175.177.

29. Seewann HL Die Jamsshidibiopsie in der klinischen Hamatologie. Methode, Indikationen und Ergebnisse and uber 1000 durchgefuhrten Biopsien unter besonderer Berucksichtigung chronischer myeloproliferativer Errankungen. Wien Med Wochenschr (Suppl) 1986:100:1-24.

30. Rappaport H, Berard CW, Butler JJ et al. Report of the commitee on histopathological criteria contributing to staging of Hodgkin´s disease. Cancer Res 1971;31:1864-1865.

31. Heckner F. Sternal Puncture. In Bone marrow pathology, edited by K Lennert and K Hübner. Gustav Fischer Verlag. Stuttgart 1994 pgs 4-5.

32. Doll DC, Ringenberg QS Anderson SP, Hewett JE Yarbro JW. Bone marrow biopsy in the initial staging of Hodgkin disease Med Pediatr Oncol 1989;17:1-7.

33. Montalban C, Rivas C, Oliva H y Sanchez.Fayos J. La biopsia de médula ósea en la enfermedad de Hodgkin. Bol Fund Jimenez Diaz 1983;10:121-127.

34. Pond GD, Castellino RA, Horning S, Hope RT. Non Hodgkin lymphoma: influence of lymphography, CT and bone marrow biopsy on staging and management. Radiology 1989;170:159-164.

35. Bennett JM, Clain KC, Glick JH, Johnson GJ, Ezdinli E, O`Connell MJ. Significance of bone marrow involvement in non-Hodgkin lymphomas: the Eastern cooperative oncology group experience. J Clin Oncol. 1986;4:1462-1469.

36. Maeda K, Hyun BH, Rebuck JW. Lymphoid follicles in bone marrow aspirates. Am J Clin Pathol 1977;67:41-48.

37. Barlt R, Frisch B, Burkhardt R, Jäger K, Pappenberger R, Hoffmann F. Lymphoproliferations in bone marrow: identification and evolution, classification and staging. J Clin Pathol 1984;37:233-254.

38. Brunning RD and McKenna RW. Bone marrow manifestations of malignant lymphoma and lynphoma-like conditions. Pathol Annual 1979:14:1-59.

39. McKenna RW. Disorders of the bone marrow. In Diagnostic surgical pathol. Ed by Sternberg SS. Chap 15, pags 497-498. Raven Press , New York 1989.

40. Rywlin AM Ortega RS, Dominguez CJ. Lymphoid nodules of bone marrow: normal and abnormal. Blood 1974;43:389-400.

41. Schimd C and Issacson P. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Pathol 1992;45:745-750.

42. Faulkner-Jones BE, Howie AJ, Boughton BJ, Franklin IM. Lymphoid aggregates in bone marrow: study of eventual outcome. J Clin Pathol 1988;41:768-775.

43. Knowles DM, Athan E, Ubriaco A et al. Extranodal noncutaneous lymphoid hyperplasia represent a continuous spectrum of B-cell neoplasia: demonstration by molecular analysis. Blood 1989;73:1635-1645.

44. Flandrin G, Sigaux F, Sebahoun G; Bouffette P. Hairy cell leukemia: clinical presentation and follow up of 211 patients. Semin Oncol 1984;11:458-478.

45. Burke JS. The value of the bone marrow biopsy in the diagnosis of hairy cell leukemia. Am J Clin Pathol 1978;70:876-884.

46. Foucar K. Bone marrow pathology. American Society of Clinical Pathologist Chicago 1995.

47. Barlt R, Frisch B, Hill W, Burkhardt R, Sommerfeld W, Sund D. Bone marrow histology in hairy cell leukemia. Identification of subtypes and their prognostic significance. Am J Clin Pathol 1983;79:531-545.

48. Ortuño F; Zuazu I, Bordes R, Brunet S, Puig J, Ayats R. Valor de la biopsia ósea en los síndromes mieloproliferativos crónicos. Revisión de 80 casos. Sangre 1989;34:117-125.

49. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br. J Haematol 1982;51:189-199.

50. Delacretaz F, Schmidt PM, Piguet D, Bachmann F, Costa S. Histopatholoy of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987;87:180-186.

51. Sultan C, Scoazec JY, Imbert M. Histopathology de la moelle osseuse. Chap 2, pags 9-11. Ed Masson, Paris 1991.

52. Tricot G, Boogaerts MA, De Wolf-Peeters C, Van den Bergh H, Verwilghen RL. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 1985;59:659-670.

53. Lambertenghi G, Annaloro C, Oriani A, Soligo D, Pozzoli E, Polli EE. Prognostic relevance of histological findings on bone marrow biopsy in myelodisplastic syndromes. Ann Hematol 1993;66.85-91.

54. Oriani A, Annaloro C, Soligo D, Pozzoli E, Cortelezzi A, Lambertenghi G. Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes.

55. Horny HP, Wehrmann M, Schlicker HU; Eichstaedt A, Clemens MR Kaiserling E. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimen. J Clin Pathol 1995;48:291-294.

56. Lambertenghi G, Annaloro C, Soligo D, Oriani A. The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes. Leuk-Lymphoma 1998;28:231-239.

57. Orazi A, Cattoretti G, Soligo D, Luksch R Lambertenghi G. Therapy related myelodysplastic syndromes: FAB classification bone marrow histology, and immunohistology in the prognostic assessment. Leukemia 1993;7:838-847.

58. Anner RM, Drewinko B. Frequency and significance of bone marrow involvement by metastatic solid tumors. Cancer 1977;39:1337-1344.

59. Levitan N, Byrne RE Bromer RH et al. The value of the bone marrow scan and bone marrow biopsy staging small cell lung cnacer. Cancer 1985;56.652-654.

60. Pasini F, Pelosi G, Santo A. L´uso di anticorpi monoclonali che riconoscono la neural adhesion molecule (NCAM) nelle diagnosi delle localizzacione midollari di microcitoma polmonare. Minerva med 1994;85:433-438.

61. Castella A, Croxson TS, Mildvan D, Witt DH, Zalusky R. The bone marrow in AIDS. A histologic, hematologic and microbiologic study. Am J Clin Pathol 1985;84;425-432.

62. Osborne BM, Guarda LA, Butler JJ. Bone marrow biopsies in patients with acquired immunodeficiency syndrome. Human Pathol 1984;15:1048-1053.

63. Benito N, Nuñez A, Gárgolas M et al. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with acquired immunodeficiency syndrome. Arch Intern Med 1997;157:1577-1580.

64. Wittels B. Surgical patholy of the bone marrow. In Major problems in pathology Edited by JL Bennington Vol 17, p 121-132. W B Saunders Compant Philadelphia 1983.

65. Najean Y, Arrago JP, delsol G, Diebold J, Horchowski N. Diagnostic and prognostic value of bone marrow biopsy in aplastic anemia. A study of 119 cases. Nouv Rev Fr Hematol 1986;28:281-285.

66. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 1982;61:269-292.

67. Smith JW. Fever of undetermined origin: not what is used to be. Am J Med Sci 1986;292:56-64.

68. Volk EE, Miller ML, Kirkley BA, Washington JA,. The diagnostic usefulness of bone marrow cultures in patients with fever of unknown. Am J Clin Pathol 1998;110:150-153.

Volver al Índice

  Fecha de última modificación: 18 agosto, 1999

Copyright. Dr. Tomás Alvaro Narajo, Dr. Llorenç Font Ferré, 1994-1999. Todos los derechos reservados